Figure 3
Comparison of MMP-2 staining before (A) and 3 months after (B) ivabradine treatment. The difference in staining score reached significance (p = 0.048) (C).
Figure 3 | BMC Cardiovascular Disorders
Comparison of MMP-2 staining before (A) and 3 months after (B) ivabradine treatment. The difference in staining score reached significance (p = 0.048) (C).